Drugs / SKYVaricella®
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07415252 | Jun 2026 → Feb 2027 expected | chickenpox | SK Bioscience Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SKYVaricella | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07415252 ↗ |
| Modality | Vaccine | “SKYVaricella® is a licensed live attenuated varicella virus vaccine” NCT07415252 ↗ |